Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients

Lung squamous cell carcinoma (LUSC) is a common type of lung cancer with high incidence and mortality rate. Tumor mutational burden (TMB) is an emerging biomarker for selecting patients with non-small cell lung cancer (NSCLC) for immunotherapy. This study aimed to reveal TMB involved in the mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Dan, Chen, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079676/
https://www.ncbi.nlm.nih.gov/pubmed/33907270
http://dx.doi.org/10.1038/s41598-021-88694-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079676/
https://www.ncbi.nlm.nih.gov/pubmed/33907270
http://dx.doi.org/10.1038/s41598-021-88694-7

Ejemplares similares